| If you have not already registered for Full Text Access to The Journal, then visit our registration page. | VOLUME 68 2007 NUMBER 11Editorial 1638 Early Career Psychiatrists Section. Marlene P. Freeman Original Articles 1639 Virtual Reality Exposure Therapy for the Treatment of Posttraumatic
Stress Disorder Following September 11, 2001. JoAnn Difede, Judith Cukor, Nimali Jayasinghe, Ivy Patt, Sharon Jedel,
Lisa Spielman, Cezar Giosan, and Hunter G. Hoffman 1648 Vitamin B6 Treatment for Tardive Dyskinesia: A Randomized,
Double-Blind, Placebo-Controlled, Crossover Study. Vladimir Lerner, Chanoch Miodownik, Alexander Kaptsan, Yuly Bersudsky,
Igor Libov, Ben-Ami Sela, and Eliezer Witztum 1655 Diagnosing Co-Occurring Substance-Related Disorders: Agreement Between SCID, Hispanic Clinicians, and Non-Hispanic Clinicians. Luis R. Torres, Luis H. Zayas, Leopoldo J. Cabassa, and M. Carmela Prez 1663 A Randomized, Double-Blind, Placebo-Controlled Trial of Desvenlafaxine
Succinate in Adult Outpatients With Major Depressive Disorder. Michael R. Liebowitz, Paul P. Yeung, and Richard Entsuah 1673 A Comparison of Selected Risk Factors for Unipolar Depressive Disorder,
Bipolar Affective Disorder, Schizoaffective Disorder, and Schizophrenia From a
Danish Population-Based Cohort. Thomas Munk Laursen, Trine Munk-Olsen, Merete Nordentoft, and Preben Bo
Mortensen 1682 Blood Glucose and Schizophrenia: A Systematic Review of Prospective
Randomized Clinical Trials. Chris J. Bushe and Brian E. Leonard 1691 Gabapentin Reduces Alcohol Consumption and Craving: A Randomized,
Double-Blind, Placebo-Controlled Trial. Fernando A. Furieri and Ester M. Nakamura-Palacios 1701 Antidepressant Medication Treatment Failure Does Not Predict Lower
Remission With ECT for Major Depressive Disorder: A Report From the Consortium
for Research in Electroconvulsive Therapy. Keith G. Rasmussen, Martina Mueller, Rebecca G. Knapp, Mustafa M. Husain,
Teresa A. Rummans, Shirlene M. Sampson, M. Kevin O'Connor, Georgios Petrides,
Max Fink, and Charles H. Kellner 1707 Efficacy and Safety of Duloxetine 60 mg Once Daily in the Treatment of
Pain in Patients With Major Depressive Disorder and At Least Moderate Pain of
Unknown Etiology: A Randomized Controlled Trial. Stephan Brecht, Christine Courtecuisse, Catherine Debieuvre, Jens
Croenlein, Durisala Desaiah, Joel Raskin, Claude Petit, and Koen Demyttenaere 1717 Clinical Characteristics and Psychiatric Comorbidity of Pyromania. Jon E. Grant and Suck Won Kim 1723 Improvement in Subjective Sleep in Major Depressive Disorder With a
Novel Antidepressant, Agomelatine: Randomized, Double-Blind Comparison With
Venlafaxine. Patrick Lemoine, Christian Guilleminault, and Enric Alvarez 1733 A 12-Week Randomized Clinical Trial to Evaluate Metabolic Changes in
Drug-Naive, First-Episode Psychosis Patients Treated With Haloperidol, Olanzapine, or Risperidone. Rocio Perez-Iglesias, Benedicto Crespo-Facorro, Jose Antonio Amado, Maria
Teresa Garcia-Unzueta, Maria Luz Ramirez-Bonilla, Cesar Gonzalez-Blanch, Obdulia
Martinez-Garcia, and Jose Luis Vazquez-Barquero 1741 Suicidal Behavior in Obsessive-Compulsive Disorder. Prakash Kamath, Y. C. Janardhan Reddy, and Thennarasu Kandavel 1751 The Texas Medication Algorithm Project Antipsychotic Algorithm for
Schizophrenia: 2006 Update. Troy A. Moore, Robert W. Buchanan, Peter F. Buckley, John A. Chiles,
Robert R. Conley, M. Lynn Crismon, Susan M. Essock, Molly Finnerty, Stephen R.
Marder, Del D. Miller, Joseph P. McEvoy, Delbert G. Robinson, Nina R. Schooler,
Steven P. Shon, T. Scott Stroup, and Alexander L. Miller 1763 Maintenance Treatment With Risperidone or Low-Dose Haloperidol in
First-Episode Schizophrenia: 1-Year Results of a Randomized Controlled Trial
Within the German Research Network on Schizophrenia. Wolfgang Gaebel, Mathias Riesbeck, Wolfgang Wlwer, Ansgar Klimke,
Matthias Eickhoff, Martina von Wilmsdorff, Maria C. Jockers-Scherbl, Kai-Uwe
Khn, Matthias Lemke, Andreas Bechdolf, Stefan Bender, Detlef Degner, Ralf
Schlsser, Lutz G. Schmidt, Andrea Schmitt, Markus Jger, Gerd Buchkremer, Peter
Falkai, Stefan Klingberg, Wolfgang Kpcke, Wolfgang Maier, Heinz Hfner,
Christian Ohmann, Hans J. Salize, Frank Schneider, and Hans-Jrgen Mller, for
the German Study Group on First-Episode Schizophrenia Early Career psychiatrists 1775 Early Careers and New Data. Marlene P. Freeman 1776 A Systematic Review of Rates and Diagnostic Validity of Comorbid Adult
Attention-Deficit/Hyperactivity Disorder and Bipolar Disorder. Aliza P. Wingo and S. Nassir Ghaemi 1785 Comparison of Antidepressant Use Between Subjects With Bipolar Disorder
and Major Depressive Disorder With or Without Comorbid Anxiety. Ayal Schaffer, John Cairney, Scott Veldhuizen, Amy Cheung, and Anthony
Levitt 1793 Effect of Olanzapine, Risperidone, and Haloperidol Treatment on Weight
and Body Mass Index in First-Episode Schizophrenia Patients in India: A
Randomized, Double-Blind, Controlled, Prospective Study. Sahoo Saddichha, Narayana Manjunatha, Shahul Ameen, and Sayeed Akhtar Academic Highlights 1799 The Roadmap for Antipsychotic Psychopharmacology: An Overview. [CME]
ASCP Corner 1807 Teaching and Practicing Psychopharmacology. John M. Kane A Psychiatrist's Diary 1809 Are You Analyzing Me? Shyam K. Bhat Letters TO the Editor [PDF] 1811 Response to Self-Injurious Behaviors in a Community Sample of Young
Women. Paul L. Plener and Efrosini Kokaliari Reply by Angela Favaro, Silvia Ferrara, and Paolo Santonastaso 1812 Aripiprazole and Perphenazine: No Difference. Robert A. Rosenheck Reply by John M. Kane, Herbert Y. Meltzer, William H. Carson, Jr., Robert
D. McQuade, Ronald N. Marcus, and Raymond Sanchez 1814 A Case of Aripiprazole-Related Tardive Akathisia and Its Treatment With
Ropinirole. John M. Hettema and David E. Ross 1815 Aripiprazole Treatment of Patients With Borderline Personality Disorder. Marius K. Nickel
Book Reviews 1817 [PDF] Electronic CME Activities Available through www.psychiatrist.com/toc e26 Recognition and Treatment of Panic Disorder. R. Bruce Lydiard e27 A Clinician's View of the Data on Bipolar Disorder. Noel C. Gardner e28 The Effect of Stimulant Treatment for ADHD on Later Substance Abuse and the Potential for Medication Misuse, Abuse, and Diversion. Stephen V. Faraone and Himanshu P. Upadhyaya |